Ikonomidis, I., Katogiannis, K., Kyriakou, E., Taichert, M., Katsimaglis, G., Tsoumani, M., Andreadou, I., Lambadiari, V., Maratou, I., Kousathana, F., Varlamos, C., Plotas, P., Alexopoulos, D., Dimitriadis, G., & Tsantes, A. (n.d.). beta-amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease. European heart journal, 41, . http://access.bl.uk/ark:/81055/vdc_100117806798.0x000023